Instead, several human cancer genomes show homo and heterozygous deletions in MCM9 coding regions, many missense mutations in MCM8 and MCM9, and altered expression levels that correlate with aggressive clinical features and poorer long-term survival in several human cancers (10, 29, 30, 31). Here, MCM9 is linked to cancer.